SCHEMBL1906147

SCHEMBL1906147

CC(N)(CCO)S(=O)(=O)O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11118339 0.80 FDPS (0.39) GRM4
SCHEMBL932090 0.80 LMNA (0.36) GRM4
SCHEMBL6772025 0.79
SCHEMBL28981611 0.78 LMNA (0.35)
SCHEMBL29045019 0.76
Sulfuric Acid SCHEMBL5424307 0.75 ALDH1A1 (0.30) GRM4
SCHEMBL6770429 0.74
SCHEMBL28613244 0.74 ALDH1A1 (0.32)
SCHEMBL8536353 0.74
SCHEMBL27959765 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178489-B2 Liquid, in a buffer which has a pH of 4.8 to 6.7; Aviptadil (VIP, vasoactive intestinal peptide); storage stability; use treating hypertension, cancer, respiratory system disorders, genetic disorders, neurodegenerative diseases MONDOBIOTECH AG (CH) 2012-05-15 US claimed
EP-1855661-B1 FORMULATION FOR AVIPTADIL MONDOBIOTECH AG (CH) 2011-05-04 EP claimed
US-20080161237-A1 Formulation For a Viptadil RELIEF THERAPEUTICS INTERNATIONAL SA (CH) 2008-07-03 US claimed
EP-1855661-A1 FORMULATION FOR AVIPTADIL MondoBIOTECH Licensing Out AG (CH) 2007-11-21 EP claimed
WO-2006094764-A1 FORMULATION FOR AVIPTADIL MONDOBIOTECH LICENSING OUT AG (CH) 2006-09-14 WO claimed
CN-1091315-A Fibrin sealant compositions and using method thereof SQUIBB & SONS INC (US) 1994-08-31 CN claimed
CN-115697973-A Sulfonic acid quaternary ammonium salt containing multifunctional active hydrogen group 株式会社德山 2023-02-03 CN disclosed
CN-115003767-A Aqueous coating composition and method for forming multilayer coating film 关西涂料株式会社 2022-09-02 CN disclosed
CN-114965623-A Measurement of ionic strength using closed-loop electrochemical pH adjustment 罗伯特·博世有限公司 2022-08-30 CN disclosed
CN-111758019-A System for dynamic light detection masking and method of use thereof 贝克顿·迪金森公司 2020-10-09 CN disclosed
CN-110799826-A Device for dissociating biological tissue samples and method of use thereof 贝克顿·迪金森公司 2020-02-14 CN disclosed
CN-107699541-A Use the angiogenesis of placenta stem-cell 人类起源公司 2018-02-16 CN disclosed
US-20170151835-A1 TIRE BRIDGESTONE CORPORATION (JP) 2017-06-01 US disclosed
CN-102933703-A Angiogenesis using placental stem cells ANTHROGENESIS CORP 2013-02-13 CN disclosed
CN-102822330-A Treatment of bone-related cancers using placental stem cells ANTHROGENESIS CORP 2012-12-12 CN disclosed
CN-100430447-C Ink, ink for ink-jet printer, method for reducing scorching on surface of heater for ink-jet recording heat, ink-jet recording method and device, recorder CANON KK (JP) 2008-11-05 CN disclosed
EP-1335886-A1 SIZING COMPOSITION Crompton Corporation (US) 2003-08-20 EP disclosed
WO-2002036515-A1 SIZING COMPOSITION CROMPTON CORPORATION (US) 2002-05-10 WO disclosed
CN-1320667-A Ink, ink for ink-jet printer, method for reducing scorching on surface of heater for ink-jet recording heat, ink-jet recording method and device, recorder CANON KK (JP) 2001-11-07 CN disclosed
CN-1091315-A Fibrin sealant compositions and using method thereof SQUIBB & SONS INC (US) 1994-08-31 CN disclosed